An international, multicenter, real-world analysis of epithelial ovarian cancer treatment and outcomes.
Geoff Hall(University of Leeds), Mariana Guergova-Kuras(IQVIA (France)), Eun Ji Nam(Yonsei University), Bethany Levick(Leeds Teaching Hospitals NHS Trust), Subin Lim(Yonsei University Health System), Joana Savva-Bordalo(IPO Porto), Sven Becker(Laboratoire National Henri Becquerel), Paul Kubelac(Iuliu Hațieganu University of Medicine and Pharmacy), Patriciu Achimaș-Cădariu(Iuliu Hațieganu University of Medicine and Pharmacy), Jean‐Marc Classe(Institut de Cancérologie de l'Ouest), Marina Borges(IPO Porto), Nicolas Niklas(Goethe University Frankfurt), Shabnam Shaid(Goethe University Frankfurt), Sue Cheeseman(Clinical Trial Investigators), E. Martin(Institut de Cancérologie de l'Ouest)
Cited by 0
Related Papers
Ubiquitination and selective autophagy
|Cell Death and Differentiation|2012|769
Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer
|JAMA Oncology|2021|196
Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases
|Clinical and Translational Allergy|2019|127
ARIA guideline 2019: treatment of allergic rhinitis in the German health system
|Allergologie select|2019|124